Bausch + Lomb Co. (NYSE:BLCO – Get Rating) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totalling 3,520,000 shares, an increase of 6.0% from the August 15th total of 3,320,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the short-interest ratio is currently 2.9 days.
Analysts Set New Price Targets
A number of analysts recently commented on the stock. HC Wainwright assumed coverage on shares of Bausch + Lomb in a report on Monday, September 12th. They set a “buy” rating and a $21.00 price objective on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Bausch + Lomb in a report on Tuesday, May 31st. They issued a “hold” rating and a $19.00 price target on the stock. Jefferies Financial Group assumed coverage on shares of Bausch + Lomb in a report on Tuesday, May 31st. They issued a “buy” rating and a $25.00 price target on the stock. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $19.00 price target (down previously from $22.00) on shares of Bausch + Lomb in a report on Tuesday, August 30th. Finally, Citigroup assumed coverage on shares of Bausch + Lomb in a report on Monday, June 6th. They issued a “buy” rating and a $22.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Bausch + Lomb has an average rating of “Moderate Buy” and a consensus price target of $23.23.
Hedge Funds Weigh In On Bausch + Lomb
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Lazard Asset Management LLC acquired a new position in Bausch + Lomb during the second quarter worth approximately $34,000. Legal & General Group Plc acquired a new position in Bausch + Lomb during the second quarter worth approximately $153,000. Oppenheimer Asset Management Inc. acquired a new position in Bausch + Lomb during the second quarter worth approximately $177,000. CSS LLC IL acquired a new position in Bausch + Lomb during the second quarter worth approximately $182,000. Finally, Point72 Hong Kong Ltd acquired a new stake in shares of Bausch + Lomb in the second quarter worth $256,000. Institutional investors and hedge funds own 10.32% of the company’s stock.
Bausch + Lomb Price Performance
Bausch + Lomb Company Profile
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye.
- Get a free copy of the StockNews.com research report on Bausch + Lomb (BLCO)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- General Mills: Superior Returns With Less Volatility
Receive News & Ratings for Bausch + Lomb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch + Lomb and related companies with MarketBeat.com's FREE daily email newsletter.